Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by palinc2000on Aug 05, 2022 8:49pm
129 Views
Post# 34875775

RE:RE:RE:RE:RE:RE:RE:RE:RE:The real quick story of Thera

RE:RE:RE:RE:RE:RE:RE:RE:RE:The real quick story of Thera

My background is in the business world,In my mind Paul 's experience , methodology , vision and brain trust is exactly what the company needed
Sorry that you can'y see how transformative THTx has been since zPaul joined....The whole Country shut down completely s few days after he joined
.... and prevented  Paul ftom speeding up the recovery and the rebranding...You and others will be surprised in a short time at the sales performance and the support from new market participants with or  without success in the oncology platform
I wrote a few weeks ago that the foundations for a rebranded company were in place and all that remains is the number of stories will be erected on those foundations .... The pandemic is over .... We will reap the benefits of the transformation but if you are just fixated on oncology then you wont be able to fully appreciste the change except for a rising share price ....The transformation is not about winning the lottery but about building a company for the long term... If against high odds ThtX wins the Lottery then we all win but the Company cannot be built on such expectations.... Life does not work that way
 

Bucknelly21 wrote: Sorry for the errors


palinc i will say i value your posts very much, on the other hand paul was your savior and supposed be the right face for the company. he hasn't created 1 ounce of value for shareholders since taking over for luc, do you fell the same way?

 

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse